Jody A. Charnow

Editor

Jody A. Charnow has been the editor of Renal & Urology News, a publication of Haymarket Media, since 2003. Previously, he had served as editor of Internal Medicine World Report and a managing editor for Medical Tribune. He holds a BA in biology from the State University of New York at Albany.

All articles by Jody A. Charnow

Prostate Cancer

Adding Talazoparib to Enzalutamide Appears Beneficial in mCRPC With HRR Mutations

Jody A. Charnow

June 9, 2023

Adding talazoparib to first-line treatment with enzalutamide improves rPFS in patients with HRR-deficient mCRPC, a phase 3 trial suggests.

Prostate Cancer

PSA Nadir After RT+ADT for Prostate Cancer Predicts Outcomes

Jody A. Charnow

June 8, 2023

New findings could have a role in conducting clinical trials of novel systemic therapies.

Kidney Cancer

Adding CN to Immunotherapy for Metastatic Kidney Cancer Improves Survival

Jody A. Charnow

June 8, 2023

Cytoreductive nephrectomy before or after immunotherapy for metastatic clear cell renal cell carcinoma improves overall survival compared with immunotherapy alone, new findings suggest.

American Transplant Congress

Low-Dose mTOR Inhibitor Combo Safe in De Novo Kidney Transplant Recipients

Jody A. Charnow

June 6, 2023

Findings from a prospective, randomized trial indicate that wound healing problems observed in early studies of high exposure to mTOR inhibitors can be prevented by using a dual regimen of everolimus and tacrolimus in low doses.

American Transplant Congress

Dialysis Modality Affects Atrial Fibrillation Risk After Kidney Transplantation

Jody A. Charnow

June 6, 2023

Patients receiving their first kidney transplant are at 18% higher risk for newly diagnosed atrial fibrillation if they were on hemodialysis rather than peritoneal dialysis prior to transplantation, a study found.

Physician, patient, examine, hospital bed, clipboard, patient chart

American Transplant Congress

Slow Graft Function After Kidney Transplantation Portends Worse Outcomes

Jody A. Charnow

June 5, 2023

Although slow graft function does not necessitate dialysis, it is associated with a higher risk for graft failure and patient death, according to investigators.

Illustration of Enterobacteriaceae bacteria

American Transplant Congress

ESBL-Producing Microbes in Post-Transplant Bacteremia Do Not Up Death Risk

Jody A. Charnow

June 5, 2023

Kidney transplant recipients with bacteremia may be more likely to require outpatient parenteral antibiotics if the infection is caused by bacteria that produce extended-spectrum beta-lactamases.

AUA 2023 Annual Meeting

The EMBARK Trial: An Interview With Neal D. Shore, MD

Jody A. Charnow

May 19, 2023

The phase 3 EMBARK trial involved more than 200 global sites and had 8 years of follow-up.

Nima Nassiri, MD, of Keck Medicine at the University of Southern California in Los Angeles.

Bladder Cancer

Trial Launched to Perform First Human Bladder Transplant

Jody A. Charnow

May 18, 2023

Following their research using pigs and brain-dead deceased donors, investigators with Keck Medicine at the University of Southern California in Los Angeles are gearing up to transplant a bladder into a living patient for the first time in history.

Transurethral resection of the prostate (TURP)

AUA 2023 Annual Meeting

TURP Still Most Common BPH Procedure Despite Growing Use of Other Therapies

Jody A. Charnow

May 12, 2023

Some studies show that use of transurethral resection of the prostate, long the gold standard for managing enlarged prostates, is in decline, but it still remains the most popular choice among surgeons amid a wide range of options.

Next post in AUA 2023 Annual Meeting